O98.7 Human immunodeficiency virus [HIV] disease complicating pregnancy, childbirth and the puerperium

Name of the Condition

• Human immunodeficiency virus [HIV] disease complicating pregnancy, childbirth and the puerperium
• Medical Code: O98.7

Summary

This condition describes HIV infection that occurs during pregnancy, childbirth, or the postpartum period (puerperium). It requires specialized management to address both maternal health and potential transmission risks to the fetus or newborn. The interaction between HIV and pregnancy-related physiological changes can complicate care, emphasizing the need for coordinated medical oversight.

Causes

The condition is caused by an active HIV infection in a pregnant individual. The virus’s impact on the immune system, combined with pregnancy-related immune modulation, can alter disease progression and transmission dynamics. Untreated or poorly controlled HIV increases risks for both maternal and fetal outcomes.

Risk Factors

• Pre-existing HIV infection
• Inadequate antiretroviral therapy (ART) adherence
• High viral load at conception or during pregnancy
• Late HIV diagnosis during pregnancy
• Lack of prenatal care or screening

Symptoms

Symptoms may include those typical of HIV infection, such as fever, fatigue, swollen lymph nodes, or weight loss. Pregnancy-specific symptoms (e.g., nausea, breast tenderness) may overlap, but HIV-related complications like opportunistic infections or immune dysfunction can also manifest. Some individuals may remain asymptomatic initially.

Diagnosis

Diagnosis involves confirming HIV infection through standard testing (e.g., ELISA, Western blot) and assessing viral load/CD4 counts. Prenatal screening protocols often include HIV testing, with confirmatory testing if initial results are positive. Monitoring during pregnancy evaluates disease progression and treatment response.

Treatment Options

• Antiretroviral therapy (ART): Essential to suppress viral load, reduce transmission risk, and maintain maternal health. Regimens are tailored to pregnancy and may adjust postpartum.
• Regular prenatal monitoring (viral load, CD4, liver/kidney function)
• Delivery planning (e.g., scheduled C-section if viral load is detectable)
• Postpartum care for mother and infant (e.g., infant prophylaxis, breastfeeding guidance)

Prognosis and Follow-Up

With proper ART and care, maternal outcomes are generally favorable, and vertical transmission rates are low. Follow-up includes ongoing viral load monitoring, adherence support, and long-term HIV management. Infants require testing and prophylaxis, with pediatric follow-up to assess infection status.

Complications

• Mother-to-child transmission (without intervention)
• Opportunistic infections (e.g., pneumonia, candidiasis)
• Preterm birth or low birth weight
• Maternal immune compromise affecting pregnancy course
• Postpartum complications (e.g., infection, delayed healing)

Lifestyle & Prevention

• Consistent ART adherence to suppress viral load
• Safe sex practices to avoid reinfection or transmission
• Prenatal care to monitor health and adjust treatment
• Avoiding substance use that may interfere with ART
• Breastfeeding decisions (guided by viral load and infant prophylaxis)

When to Seek Professional Help

Seek care if experiencing HIV-related symptoms (e.g., persistent fever, unexplained weight loss) or pregnancy complications (e.g., preterm labor, infection signs). Urgent evaluation is needed for symptoms of opportunistic infections or if ART adherence is compromised.

Tips for Medical Coders

Document the presence of HIV complicating pregnancy, childbirth, or the puerperium. Code O98.7 is appropriate when HIV is the primary complicating factor. Ensure documentation specifies the timing (pregnancy, labor, or postpartum) and any related interventions (e.g., ART, transmission prevention measures) to support accurate coding.